Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in ALEC — Alector, Inc.

CIK 1692234 Seattle, WA
Back to ALEC Full portfolio

Position in ALEC

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$197,973
+$55,794 QoQ
Shares Held
98,496
+48.9% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 140 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in ALEC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. ALEC ranks #183 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in ALEC

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $197,973 98,496
2026-03-31 $142,179 66,131
2025-12-31 $112,141 71,887
2025-09-30 $310,276 104,824
2025-06-30 $140,511 100,366
2025-03-31 $65,706 53,421
2024-12-31 $106,290 56,239
2024-09-30 $338,431 72,625
2024-06-30 $380,510 83,813
2024-03-31 $471,654 78,348
2023-12-31 $568,830 71,282
2023-09-30 $778,377 120,120
2023-06-30 $601,089 100,015
2023-03-31 $936,311 151,262
2022-12-31 $1,036,611 112,309
2022-09-30 $801,402 84,715
2022-06-30 $557,986 54,920
2022-03-31 $144,780 10,160
2021-12-31 $209,804 10,160
2021-03-31 $852,264 42,317
2020-12-31 $1,025,919 67,807
2020-09-30 $737,449 70,000
2020-06-30 $1,655,345 67,731
2020-03-31 $2,128,845 88,224